How to shorten timelines to first in human.

Getting your early development process right from the start can help save time and money as you advance through each phase and on to commercialization. Our early development global experts and scientists are here to support every step of your project. Gain access to an integrated drug program for flexible and tailored solutions to:

  • Accelerate your project to First-in-Human (FIH) studies
  • Rapidly characterize your drug substance
  • Overcome formulation challenges such as low bioavailability
  • Gain a clear view of your path through preclinical and clinical studies
  • Design, validate, and implement analytical and process methodologies
  • Generate the data required for IND filings

Gain access to a variety of early development programs that enable speed and flexibility into your small molecule’s lifecycle:

  • Quick to Clinic™ helps reduce the time it takes to get your discovery to patients
  • Quadrant 2™ analyzes your compound’s specific molecular structure and chemical characteristics, in combination with your unique target product profile
  • Quick to Care™ streamlines the supply chain and accelerating development
  • Continuous Manufacturing provides flexibility and cost savings within manufacturing